Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
May 09, 2017 13:34 pm UTC| Business
DANVERS, Mass., May 09, 2017 -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation Impella CP heart pump at the Annual...
May 09, 2017 13:31 pm UTC| Business
Sarasota, FL, May 09, 2017 -- Zion Market Research, the market research group announced the analysis report titled "Luxury Hotels Market By Type (Business Hotels, Suite Hotels, Airport Hotels, Resorts) - Global Industry...
Eventide Healthcare & Life Sciences Fund Named WSJ Category King for Health & Biotech
May 09, 2017 13:30 pm UTC| Business
BOSTON, May 09, 2017 -- The Eventide Healthcare Life Sciences Fund (NASDAQ:ETAHX)(NASDAQ:ETCHX)(NASDAQ:ETIHX) (NASDAQ:ETNHX) was named as a Wall Street Journal “Category King” for the Health Biotech Category for the...
Navios Maritime Partners L.P. Announces Acquisition of One Capesize Vessel
May 09, 2017 13:30 pm UTC| Business
MONACO, May 09, 2017 -- Navios Maritime Partners L.P. ("Navios Partners") (NYSE:NMM), an international owner and operator of drybulk and container vessels, announced today that it has agreed to acquire one 2011 South...
Painters District Council No. 30 Awards Grant to A Soldier’s Journey Home
May 09, 2017 13:27 pm UTC| Business
AURORA, Ill., May 09, 2017 -- Painters District Council No. 30 (PDC 30) has selected an award recipient for its Spring 2017 Community Service Grant. The organization, A Soldier’s Journey Home, has a mission familiar to...
Gladstone Investment Corporation Prices Common Stock Offering
May 09, 2017 13:19 pm UTC| Business
MCLEAN, Va., May 09, 2017 -- Gladstone Investment Corporation (NASDAQ:GAIN) (the “Company”) today announced that it has entered into an agreement to sell 2,100,000shares of its common stock at a public offering price of...
Merus Announces Annual Meeting of Shareholders
May 09, 2017 13:17 pm UTC| Business
UTRECHT, The Netherlands, May 09, 2017 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that the Annual General Meeting of...